Intervet/Schering-Plough Animal Health has officially opened its state-of-the-art production center for veterinary vaccines against bacterial infections. The new facility is located at the Biosciences Center Boxmeer in the Netherlands.
Intervet/Schering-Plough Animal Health is investing US$ 22 mln in the new building, which has increased the floor space of the bacterial vaccine production unit by more than three-fold from approx. 1,500 to over 5,500 m2. It will have 4 hi-tech production lines for bacterial vaccines with a media preparation capacity in fermentors ranging from 200 to 1,500 liters. The availability of state-of-the-art fermentors and clean rooms, in combination with efficient, integrated up-/downstream processing operations and automation makes the new unit a landmark in veterinary bacterial vaccine manufacturing.
The official opening of the new manufacturing facility was performed by Chris Buijink, secretary-general of the Dutch Ministry of Economic Affairs, and was celebrated with a dedicated scientific symposium titled “Research and Technology in Bacterial Vaccine Development: Opportunities for a One Health Approach”. The symposium has been organized in collaboration with Immuno Valley, and several experts from Dutch universities and research institutions will present on new developments in bacterial vaccine R&D and manufacturing with the “One Health” approach as an overarching theme.
The facility, of which the building activities have started in December 2007, is fully compliant with current and anticipated regulatory requirements on Good Manufacturing Practices (GMP) for veterinary medicines, with special sectors for bio-contained zones. In addition, the new facility allows production capacity to be expanded in order to meet the increasing demand for veterinary vaccines.